Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heat-Shock Proteins | 17 | 2023 | 194 | 5.100 |
Why?
|
| Molecular Chaperones | 12 | 2023 | 169 | 2.740 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2017 | 274 | 2.300 |
Why?
|
| Saccharomyces cerevisiae | 7 | 2023 | 422 | 1.800 |
Why?
|
| HSP70 Heat-Shock Proteins | 8 | 2023 | 69 | 1.640 |
Why?
|
| Adenosine Triphosphate | 8 | 2022 | 288 | 1.540 |
Why?
|
| Models, Molecular | 22 | 2021 | 1069 | 1.330 |
Why?
|
| Thermus thermophilus | 5 | 2012 | 10 | 1.000 |
Why?
|
| Leishmania | 2 | 2023 | 29 | 0.990 |
Why?
|
| Mitochondria | 5 | 2023 | 670 | 0.930 |
Why?
|
| Bacterial Proteins | 5 | 2012 | 876 | 0.920 |
Why?
|
| Protein Folding | 7 | 2016 | 216 | 0.920 |
Why?
|
| Escherichia coli Proteins | 5 | 2022 | 303 | 0.910 |
Why?
|
| HSP90 Heat-Shock Proteins | 4 | 2020 | 35 | 0.890 |
Why?
|
| Protein Multimerization | 7 | 2021 | 122 | 0.870 |
Why?
|
| Cryoelectron Microscopy | 5 | 2019 | 212 | 0.850 |
Why?
|
| Protein Conformation | 13 | 2019 | 835 | 0.830 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2023 | 104 | 0.790 |
Why?
|
| Shewanella | 1 | 2019 | 8 | 0.670 |
Why?
|
| HSP40 Heat-Shock Proteins | 3 | 2018 | 21 | 0.670 |
Why?
|
| Adenosine Triphosphatases | 7 | 2012 | 210 | 0.660 |
Why?
|
| Binding Sites | 9 | 2022 | 1294 | 0.660 |
Why?
|
| Protein Aggregates | 2 | 2018 | 26 | 0.630 |
Why?
|
| Crystallography, X-Ray | 9 | 2017 | 357 | 0.630 |
Why?
|
| GTP-Binding Proteins | 1 | 2019 | 174 | 0.620 |
Why?
|
| Protein Unfolding | 1 | 2017 | 10 | 0.600 |
Why?
|
| Protein Structure, Tertiary | 9 | 2012 | 751 | 0.550 |
Why?
|
| Protein Binding | 7 | 2021 | 1736 | 0.490 |
Why?
|
| Mitochondrial Proteins | 2 | 2020 | 238 | 0.480 |
Why?
|
| Amino Acid Sequence | 10 | 2019 | 2701 | 0.450 |
Why?
|
| Mitochondrial Membranes | 2 | 2010 | 31 | 0.450 |
Why?
|
| Metalloendopeptidases | 2 | 2010 | 101 | 0.440 |
Why?
|
| Amino Acid Motifs | 5 | 2016 | 198 | 0.370 |
Why?
|
| Chaperonin 60 | 1 | 2010 | 32 | 0.370 |
Why?
|
| Peptides | 3 | 2022 | 799 | 0.350 |
Why?
|
| Proteolysis | 2 | 2021 | 168 | 0.340 |
Why?
|
| Substrate Specificity | 4 | 2022 | 284 | 0.330 |
Why?
|
| Molecular Sequence Data | 10 | 2016 | 3887 | 0.330 |
Why?
|
| RNA Polymerase II | 2 | 2000 | 99 | 0.310 |
Why?
|
| Endopeptidase Clp | 4 | 2021 | 7 | 0.290 |
Why?
|
| Protein Structure, Quaternary | 4 | 2012 | 98 | 0.280 |
Why?
|
| Protein Domains | 3 | 2023 | 233 | 0.270 |
Why?
|
| Escherichia coli | 6 | 2021 | 981 | 0.270 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2010 | 460 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 1354 | 0.240 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2016 | 658 | 0.230 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2023 | 27 | 0.220 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2024 | 37 | 0.220 |
Why?
|
| Leishmania mexicana | 1 | 2023 | 5 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 348 | 0.220 |
Why?
|
| Protein Structure, Secondary | 7 | 2012 | 239 | 0.220 |
Why?
|
| Cloning, Molecular | 2 | 2019 | 900 | 0.210 |
Why?
|
| Receptors, Androgen | 1 | 2006 | 408 | 0.210 |
Why?
|
| Leishmaniasis | 1 | 2023 | 33 | 0.210 |
Why?
|
| Hydrolysis | 2 | 2019 | 156 | 0.180 |
Why?
|
| Stress, Physiological | 1 | 2023 | 265 | 0.180 |
Why?
|
| Mutation | 4 | 2023 | 5782 | 0.170 |
Why?
|
| Proteins | 1 | 2005 | 1042 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 93 | 0.170 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2019 | 16 | 0.170 |
Why?
|
| Transcription Factors | 2 | 2000 | 2587 | 0.160 |
Why?
|
| Humans | 20 | 2023 | 122300 | 0.150 |
Why?
|
| Allosteric Regulation | 2 | 2016 | 48 | 0.150 |
Why?
|
| DNA Topoisomerases, Type II | 2 | 1997 | 22 | 0.150 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 25 | 0.150 |
Why?
|
| Transcription Factors, TFII | 1 | 1998 | 7 | 0.150 |
Why?
|
| Archaea | 1 | 1998 | 10 | 0.150 |
Why?
|
| Protein Transport | 2 | 2017 | 369 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2019 | 4510 | 0.150 |
Why?
|
| Novobiocin | 1 | 1997 | 2 | 0.150 |
Why?
|
| Coumarins | 1 | 1997 | 23 | 0.140 |
Why?
|
| 5'-Nucleotidase | 1 | 2016 | 16 | 0.130 |
Why?
|
| Allosteric Site | 1 | 2016 | 11 | 0.130 |
Why?
|
| tau Proteins | 1 | 2018 | 186 | 0.130 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 390 | 0.130 |
Why?
|
| Crystallization | 2 | 2007 | 82 | 0.130 |
Why?
|
| Homeostasis | 1 | 2020 | 680 | 0.130 |
Why?
|
| Bacteria | 1 | 2019 | 483 | 0.120 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 793 | 0.120 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 180 | 0.120 |
Why?
|
| Rabbits | 1 | 2016 | 717 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2016 | 312 | 0.110 |
Why?
|
| Peptide Mapping | 1 | 2013 | 44 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2016 | 609 | 0.110 |
Why?
|
| Conserved Sequence | 2 | 2010 | 293 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 772 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1703 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 1403 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 2041 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2012 | 318 | 0.090 |
Why?
|
| Molecular Weight | 2 | 2003 | 393 | 0.090 |
Why?
|
| Enzyme Stability | 1 | 2010 | 58 | 0.090 |
Why?
|
| Hot Temperature | 1 | 2010 | 135 | 0.090 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 157 | 0.090 |
Why?
|
| Yeasts | 1 | 2009 | 43 | 0.080 |
Why?
|
| Species Specificity | 1 | 2010 | 552 | 0.080 |
Why?
|
| Fungal Proteins | 1 | 2009 | 134 | 0.080 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2006 | 123 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2021 | 349 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2021 | 287 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 250 | 0.070 |
Why?
|
| Infant | 1 | 2023 | 12341 | 0.070 |
Why?
|
| Models, Biological | 2 | 2021 | 1437 | 0.070 |
Why?
|
| Adenine Nucleotides | 1 | 2007 | 41 | 0.070 |
Why?
|
| Animals | 5 | 2023 | 33865 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1674 | 0.070 |
Why?
|
| Hormone Antagonists | 1 | 2006 | 63 | 0.070 |
Why?
|
| Mifepristone | 1 | 2006 | 138 | 0.070 |
Why?
|
| Base Sequence | 3 | 2000 | 3118 | 0.070 |
Why?
|
| Receptors, Steroid | 2 | 2005 | 269 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2007 | 620 | 0.060 |
Why?
|
| Receptors, Progesterone | 2 | 2006 | 865 | 0.060 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2006 | 16 | 0.060 |
Why?
|
| Heat-Shock Response | 1 | 2004 | 31 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 279 | 0.060 |
Why?
|
| Cyclophilin A | 1 | 2024 | 16 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 570 | 0.060 |
Why?
|
| Threonine-tRNA Ligase | 1 | 2023 | 1 | 0.060 |
Why?
|
| Aminoacylation | 1 | 2023 | 4 | 0.060 |
Why?
|
| Protein Denaturation | 1 | 2003 | 50 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2007 | 744 | 0.060 |
Why?
|
| RNA, Transfer | 1 | 2023 | 70 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2009 | 565 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2006 | 1615 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2746 | 0.050 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2021 | 37 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2023 | 810 | 0.040 |
Why?
|
| Protein Interaction Mapping | 1 | 2021 | 85 | 0.040 |
Why?
|
| Aldosterone | 1 | 2000 | 59 | 0.040 |
Why?
|
| Ribosomes | 1 | 2021 | 138 | 0.040 |
Why?
|
| Transcription Factor TFIIB | 1 | 2000 | 10 | 0.040 |
Why?
|
| TATA-Box Binding Protein | 1 | 2000 | 30 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 569 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 184 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2024 | 541 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2021 | 352 | 0.040 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2000 | 103 | 0.040 |
Why?
|
| Cell Survival | 2 | 2016 | 817 | 0.040 |
Why?
|
| Phylogeny | 1 | 2021 | 684 | 0.040 |
Why?
|
| Gene Expression Regulation, Archaeal | 1 | 1998 | 1 | 0.040 |
Why?
|
| DNA, Archaeal | 1 | 1998 | 2 | 0.040 |
Why?
|
| TATA Box | 1 | 1998 | 25 | 0.040 |
Why?
|
| Transcription Factor TFIID | 1 | 1998 | 13 | 0.040 |
Why?
|
| Progesterone | 1 | 2000 | 624 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 798 | 0.040 |
Why?
|
| DNA Gyrase | 1 | 1997 | 21 | 0.040 |
Why?
|
| Solutions | 1 | 1997 | 65 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 1998 | 184 | 0.040 |
Why?
|
| Thermodynamics | 1 | 1997 | 141 | 0.030 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 1996 | 13 | 0.030 |
Why?
|
| Molecular Motor Proteins | 2 | 2007 | 29 | 0.030 |
Why?
|
| COS Cells | 2 | 2006 | 273 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1934 | 0.030 |
Why?
|
| Models, Genetic | 1 | 1998 | 748 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2785 | 0.030 |
Why?
|
| Point Mutation | 2 | 2009 | 346 | 0.030 |
Why?
|
| DNA | 1 | 2000 | 1606 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 742 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 1996 | 266 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2012 | 96 | 0.030 |
Why?
|
| Hypertension | 1 | 2000 | 1265 | 0.020 |
Why?
|
| ATP-Dependent Proteases | 1 | 2009 | 10 | 0.020 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2009 | 67 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2009 | 164 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2009 | 155 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 1316 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 2948 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 385 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 1996 | 2391 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2009 | 742 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2004 | 73 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2004 | 287 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2004 | 207 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 483 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2005 | 379 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 392 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 179 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 144 | 0.010 |
Why?
|
| Female | 2 | 2023 | 64911 | 0.010 |
Why?
|
| Steroids | 1 | 2000 | 203 | 0.010 |
Why?
|
| Heterozygote | 1 | 2000 | 681 | 0.010 |
Why?
|
| 4-Quinolones | 1 | 1996 | 1 | 0.010 |
Why?
|
| Pedigree | 1 | 2000 | 1577 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 580 | 0.010 |
Why?
|
| Pregnancy | 1 | 2000 | 7103 | 0.000 |
Why?
|
| Adolescent | 1 | 2000 | 18979 | 0.000 |
Why?
|
| Male | 1 | 2000 | 59545 | 0.000 |
Why?
|